Role of Positron Emission Tomography in the Evaluation of Response to Sorafenib in Advanced Hepatocellular Carcinoma

NCT01157013 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

OTHER: Positron emission tomography with fludeoxyglucose F 18

Sponsor

Hospital Miguel Servet

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]